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Background: Many recent epigenetic studies report that cigarette smoking reduces DNA methylation in whole
blood at the single CpG site cg19859270 within the GPR15 gene.
Results: Within two independent cohorts, we confirmed the differentially expression of the GPR15 gene when
smokers and non-smokers subjects are compared. By validating the GPR15 protein expression at the cellular level,
we found that the observed decreased methylation at this site in white blood cells (WBC) of smokers is mainly
caused by the high proportion of CD3+GPR15+ expressing T cells in peripheral blood. In current smokers, the
percentage of GPR15+ cells among CD3+ T cells in peripheral blood is significantly higher (15.5 ± 7.2 %, mean ±
standard deviation) compared to non-smokers (3.7 ± 1.6 %). Treatment of peripheral blood mononuclear cell (PBMC)
cultures with aqueous cigarette smoke extract did not induce a higher proportion of this T cell subtype.
Conclusions: Our results underline that DNA hypomethylation at cg19859270 site, observed in WBCs of smokers,
did not arise by direct effect of tobacco smoking compounds on methylation of DNA but rather by the enrichment
of a tobacco-smoking-induced lymphocyte population in the peripheral blood.
Keywords: DNA methylation, CpG, GPR15, Tobacco smoking, Blood, EWAS cell compositionBackground
A surge in recent publications shows a potential link be-
tween epigenetic variation and environmental exposure
or the etiology of human diseases. For example, epigen-
etic studies have identified strong associations between
tobacco smoking and altered DNA methylation at single
sites (CpG) in peripheral blood cells [1–7] (Table 1). To
date, eight loci (including GPR15, AHRR, F2RL3) have
been confirmed at the genome-wide level to show
differential methylation when current smokers and non-
smokers are compared [5]. Epigenome-wide association
studies (EWAS) of DNA methylation using whole-blood-
derived DNA is complicated by the heterogeneity of cell
types within blood. For instance, DNA from peripheral
blood is a mixture of genetic substrate from various* Correspondence: gunda.herberth@ufz.de
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may confound true epigenetic associations between
methylation and a dependent variable of interest. There
are some approaches which aim to deconvolute subject-
specific blood composition by using DNA methylation sig-
natures of cell lineage markers [8–14]. Here, in most
cases, differentially methylated regions (DMRs) for the
lineage markers for B cells (CD19+), granulocytes
(CD15+), monocytes (CD14+), NK (CD56+), CD3+CD4+
T cells, CD3+CD8+ T cells, NKT (CD3+CD56+), other T
cells (CD3+) are used to determine the frequency of these
cells in whole blood. However, variations in minor immune
cell fractions or subtypes not covered by the yet analyzed
lineage markers may also skew DNA methylation results
relating to environmental exposure or disease outcomes.
From an immunological point of view, it is obvious that
most diseases, when T cell dependent, are linked to the fre-
quency or activation of certain T cell subtypes rather than
to CD3+ T cells in general. Asthma and inflammatoryicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 Summary of reports indicating that tobacco smoking evokes hypomethylation at single CpG sites in white blood cells
Report Hypomethylationa Methylation change
Maxb cg19859270c cg03636183c
% of CpG sites (n) (%)
Whole blood
Breitling et al., 2011 [1] 84 (13) −14 −4.3 −12.6
Wan et al., 2012 [6] 60 (15) −8 −2; −2 −8; −6
Zeilinger et al., 2013 [7] 62 (29) −25 −1.4; −2 −15; −17
Shenker et.al., 2013 [3] 83 (36) −16 n/a −7; −8
Sun et al., 2013 [4] 93 (15) −10 −2.1; −2.2 −9.6; −3
Tsaprouni et al., 2014 [5] 96 (30) −28 −3.5; −2.7 −13.4; −10.6
PBMC
Dogan et al., 2014 [2] 60 (30) −19 −10 n/a
n/a not available
aDescribes the methylation change in smokers vs. non-smokers of the prominent highlighted single CpGs
bIndicates the maximum of methylation change at single CpG
cHighlighted are values for the main and replicated cohorts of appropriate studies
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quencies of mucosal associated invariant T cells, a T cell
subtype in peripheral blood expressing CD3/CD8/CD161/
TCRa7.2 [15, 16]. A difference at CD3 level between con-
trols and cases is not detectable. This example highlights
the importance of accounting for the T cell subtype in
EWAS, independently of whether the variable of interest is
environmental exposure or disease. Therefore, in our
present study, we aimed to extend the already published
epigenetic observations regarding tobacco smoking and sin-
gle CpG hypomethylation by examining the biological sig-
nificance at cellular level. We focused on the CpG site
cg19859270 which is located in the gene body of GPR15,
an orphan chemoattractant receptor and co-receptor for
HIV. Our data show that the observed decreased methyla-
tion at this site in white blood cells (WBC) of smokers is
directly associated to the proportion of CD3+GPR15+
expressing T cells. In current smoker, the percentage of
GPR15+ cells among CD3+ T cells in peripheral blood is
significantly higher (15.5 ± 7.2 %, mean ± standard devi-
ation) compared to non-smoker (3.7 ± 1.6 %). However,
treatment of WBC cultures with aqueous cigarette smoke
extract (CSE) did not induce a higher proportion of this T
cell subtype, suggesting that an immunological cascade is
evoking GPR15 expressing lymphocytes rather than a dir-
ect and specific impact of tobacco smoke on methylation.
Results
GPR15—most differentially expressed gene in smoker vs.
non-smoker
To identify a phenotypic consequence of prominent re-
ported hypomethylation at single CpG sites by tobacco
smoking, gene expression of single CpG linked genes
(GPR15, F2RL3, AHRR, LIM2, LRRN3, MYLK, PTPRO)
was analyzed in a Working Place Cohort comprising 42active smokers and 31 non-smokers as well as 20
formerly smokers (Table 1). Out of the 159 implemented
genes of interest, differential expression of the two CpG
linked genes GPR15 and AHRR next to other non-CpG
linked genes (CCR5, CXCL7, FOXP3, ALOX12, and CCL2)
between smoker and non-smoker remained significant
after correction for multiple testing (see Additional file 1).
GPR15 expression in whole blood differed mostly with re-
spect to smoking status and independent of the daily time
of blood donation (see Additional file 2). In active smokers
(< or >10 cigarettes/day) the GPR15 expression was 5.3-
fold higher than in non-smokers (p = 4.7 × 10−19) (Fig. 1b).
Former smokers included in the Working Place Cohort
showed a significant intermediate value with a 2.0-fold
higher (p = 2.9 × 10−8) and 2.8-fold lower (p = 5.5 × 10−3)
extent toward non-smoker and smoker (<10 cigarettes/
day), respectively (Fig. 1a).
Further validation studies were performed only for
GPR15.
Replication of GPR15 gene expression
In order to confirm the relationship between differential
expression of GPR15 and smoking behavior, a replication
cohort with 100 randomly selected volunteers was
generated. The Replication Cohort comprised 18 ac-
tive smokers and 82 non-smokers (Table 1). In this co-
hort, and in a very similar range to the Working Place
Cohort, we found that GPR15 was significantly higher
expressed in blood samples of active smokers com-
pared to non-smoker (Fig. 1b).
Validation of GPR15 protein expression at the cellular
level
In order to identify the blood cell type expressing







Fig. 1 Tobacco-smoking-dependent GPR15 gene expression in
human peripheral white blood cells. Implemented were blood
specimens from two different cohorts (Working Place Cohort
(gray box plot) and Replication Cohort (black boxplot)). The GPR15
gene expression was significantly increased in smokers (a, b) as well
as formerly smokers (a), cig/d, cigarettes per day. Boxes indicate the
25 to 75 % percentile and whiskers the non-outlier range. P values
from unpaired Student’s t test
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well as peripheral blood mononuclear cells (PBMCs) from
buffy coats. The main population expressing GPR15 was
CD3+ T cells (Fig. 2a, see Additional file 3). Smokers had
a significantly (p = 1.8 × 10−10) increased proportion of
GPR15+ cells among CD3+ T cells (15.5 ± 7.2 %, mean ±
standard deviation) compared to non-smoker (3.7 ± 1.6 %,
Fig. 2b). By setting a cutoff of 9 % GPR15 expressing cells
among CD3+ T cells in blood, the flow cytometric analysis
could distinguish smoker from non-smoker with high
sensitivity (0.88 %) and high specificity (0.99 %). In
addition to T cells, a low proportion of B cells expressed
GPR15 (Fig. 2a). The proportion of CD19+GPR15+ B
cells was significantly (p = 1.5 × 10−5) higher in smoker
(7.98 ± 7.54 %) compared to non-smoker (3.81 ± 2.89 %,
Fig. 2b).Correlation between GPR15 gene expression and
frequency of GPR15+ cells in whole blood
In the Replication Cohort, GPR15 gene expression as
well as the frequency of GPR15+ lymphocytes among
CD3+ T cells and CD19+ B cells were measured in white
blood cells. The strongest correlation was found be-
tween GPR15 gene expression and the proportion of
CD3+GPR15+ T cells (R2 = 0.72, p = 8.4−28). The amount
of CD19+GPR15+ B cells was only marginally correlated
with the GPR15 gene expression in WBC (R2 = 0.12,
p = 5.0−4), Fig. 3.
Replication of GPR15 methylation differences in flow
cytometric-sorted cells
Analysis of methylation of CpG site cg19859270 located
within the GPR15 gene was performed in isolated PBMCs,
in flow cytometric-sorted CD3+GPR15+ as well as
CD3+GPR15- T cells of smokers (n = 6) and non-smokers
(n = 6). At the PBMC level, a methylation difference of
3.0 % (p = 0.009) between smoker and non-smoker was
observed as expected (Fig. 4). A hypomethylation at
cg19859270 was specific for GPR15 expressing cells inde-
pendent on smoking habit. The methylation difference be-
tween GPR15− and GPR15+ T cells was 49.5 % in smoker
(p = 0.005) and similar in non-smoker (38 %, p = 0.005).
Within the CD3+GPR15+ population, the hypomethyla-
tion of cg19859270 site was slightly more pronounced in
smokers than non-smokers (delta methylation = −15.0 %,
p = 0.029). Due to the low frequency of GPR15+ B cells,
sorting for this cell type was not performed.
Allele frequencies of SNPs within the GPR15 gene
Although the protein expression of GPR15 was only de-
tectable when the CpG site cg19859270 was markedly
hypomethylated, the hypomethylation in GPR15 express-
ing cells reached only values of about 50 %. To exclude
an underlying imprinting effect at this CpG site, we ana-
lyzed the occurrence of alleles at two single nucleotide
polymorphisms (SNP, rs3749260, rs2230344), located
within the gene body of GPR15, in genomic DNA as well
as GPR15 transcript in WBCs of randomly selected par-
ticipants of the Replication Cohort (non-smoker and
smoker, each n = 18). Since both gDNA and GPR15 tran-
scripts have shown identical proportions of alleles in
each subject, the imprinting at cg19859270 may be ex-
cluded, and thus, a random monoallelic expression of
GPR15 can be supposed (Table 2).
Association between methylation, smoking behavior, and
lymphocyte cell subpopulations
In our study, as well as in published data, a significant
hypomethylation at cg19859270 within the GPR15 gene
has been observed in smoker at WBC or PBMC level.
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Fig. 2 Percentage of GPR15 protein expressing lymphocytes in blood specimens of the Replication Cohort (91 non-smokers vs. 32 smokers in
total). a Representative dot plots gated on lymphocytes show GPR15 expression in CD3+ T cells and CD19+ B cells in smoker and non-smoker.
Percentages represent the frequency of these cells in the lymphocyte gate. b Cumulative data of the GPR15 expressing cells as percentage of
CD3+ or CD19+ lymphocytes. P values from Mann-Whitney U Test
Bauer et al. Clinical Epigenetics  (2015) 7:81 Page 4 of 11expectable. However, we clearly show that in smokers,
the proportion of GPR15 expressing cells is many times
higher than in non-smoker, implying that the observed
hypomethylation at WBC or PBMC level is determined
by the proportions of these cells in peripheral blood. By
using a linear regression model we confirmed this obser-
vation, assessing the impact of smoking, age, gender, the
proportion of CD3+ and frequency of GPR15+ cells
among CD3+ T cells on methylation at cg19859270 in
PBMCs (Table 3). In univariate analysis smoking (p =
0.011) as well as the frequency of CD3+GPR15+ T cells
(p = 0.007) show significant association to methylation atcg19859270 (Methyl-PBMC), whereas age, gender and
the proportion of CD3+ T cells did not influence this
association. However, in the multiple regression model,
the smoking-dependent association with methylation at
cg19859270 was lost by adjustment to the proportion of
CD3+GPR15+ T cells (p = 0.904).
Stimulation of PBMCs with CSE in vitro
To identify any causative role of active cigarette
smoking to the excess of GPR15+ cells in blood, we
investigated the impact of different CSE concentra-





Fig. 3 GPR15 gene expression in whole blood versus frequency of GPR15 expressing T lymphocytes. Percentage of GPR15+ of CD3+ T cells (a)
and of CD19+ B cells (b). Correlation coefficient from linear regression analysis
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tion of GPR15-expressing cells.
Discussion
In this study, we provide the first evidence that reported
tobacco smoke induced methylation changes at single
CpG site in DNA of WBC is mainly seen due to an in-
creased proportion of specialized cell subtypes in blood
rather than by direct impact of tobacco smoke on DNA
methylation. Here, we show that only the GPR15-
expressing cells are hypomethylated at cg19859270,
located within the GPR15 gene body, and thus, theobserved hypomethylation at this CpG site [1–7] in
smokers is the consequence of a higher proportion of
GPR15 expressing cells being present in the peripheral
blood. In two independent cohorts, we confirmed the
differential expression of GPR15 at the RNA level in
WBC between smoker and non-smoker and continued
the validation at the cellular protein level. By analyzing
the GPR15 protein expression in WBC subtypes, it was
evident that the proportion of CD3+GPR15+ T cells and
to a lesser extent the CD19+GPR15+ B cells were respon-
sible for the apparent smoking-induced hypomethylation in





Fig. 4 Methylation of CpG site cg19859270 in PBMCs and sorted CD3+GPR15- and CD3+GPR15+ cells. CpG was analyzed by pyrosequencing of
PBMCs and flow cytometric-sorted cells of non-smoker (white plots, n = 6) and smokers (gray plots, n = 6). P values from Mann-Whitney U Test
Table 3 Correlation of DNA methylation at cg19859270 in
PBMCs and frequency of GPR15 expressing CD3 lymphocytes in
non-smoker versus smoker
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highlight the importance of accounting not only for main
cell composition but also for cell subtypes in EWAS per-
formed in whole blood or white blood cells.
Recent EWAS have indicated a potential role of epi-
genetic changes in the etiology of human diseases or in
relation to environmental exposure. However, when per-
formed on whole blood or in general on tissue samples,
one major challenge is to distinguish true epigenetic
variation from epigenetic changes caused by differences
in cellular composition between cases and controls [17].
For example, during aging, the cellular composition of
blood is often altered [18, 19], and thus, an apparent epi-
genetic variation may be the result of age specificTable 2 Allele frequencies of two single nucleotide
polymorphisms (rs2230344, rs3749260) located within GPR15
gene at genomic and transcript level









AA 2 2profiles for different blood cell subsets. On the other
hand, the level of methylation per se varies across the life
course, declining through aging [20, 21]. Thus, adjust-
ment for age and cell composition is crucial in EWAS.
Information regarding subject age is easily accessible;
however, in contrast determination of whole blood cell
composition at a cellular level is more challenging.
Recently, a set of statistical methods have been pub-
lished aimed at overcoming cell composition bias in
EWAS. Beside reference-free methods [22, 23], the ma-
jority of methods for whole blood are based on existingMethyl-PBMC
Beta SE P value
Univariate analysis
Smoking habit −4.17 1.32 0.011
Gender −1.51 1.83 0.428
Age 0.03 0.05 0.558
CD3+ 0.11 0.07 0.171
GPR15+ of CD3+ −0.35 0.10 0.007
Multiple regression
~Smoking habita −0.71 0.33 0.008
~Smoking habitb 0.53 4.19 0.904
~GPR15+ of CD3+a −0.38 0.09 0.003
aAdjusted to gender, age, and CD3+





























Fig. 5 Influence of cigarette smoke extract (CSE) on GPR15 expression in PBMCs of randomly selected non-smokers (NS, n = 3) and smokers (S, n = 3).
PBMCs were exposed in vitro for 5 days
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entially methylated loci across major leukocyte types
[8, 14, 18]. For example, the reference set provided by
Houseman et al. [14] distinguish granulocytes from
other cell types and CD4+ and CD8+ T cells from other
cells that are not lymphocytes. However, it does not
differentiate T cell subtypes like Th1, Th2, regulatory T
cells, or memory T cells. Thus, an adjustment for the
proportion of blood cells in whole blood is possible only
at the level of cell lineage markers. Unmeasured
subpopulations or activated versions of measured cell
types with impact on the variable of interest are not
accounted for in this case. In our study we identified a T
cell subtype expressing the orphan chemoattractant
receptor GPR15 which is specifically enriched in active
smokers. Starting at the level of white blood cells, we
identified GPR15 as the most differentially expressed
gene in smokers vs. non-smokers in two independent
cohorts. Former smokers showed an intermediate level
of expression of GPR15 (Fig. 1). These data are in line
with results in recently published studies [24, 5].
Tsaprouni et al. observed a correlation between DNA
hypomethylation in cg19859270 and GPR15 gene ex-
pression in white blood cells of smokers indicating that
cigarette smoking reduces DNA methylation [5]. How-
ever, GPR15 protein expression at the cellular level has
not been analyzed yet in relation to smoking status.
Therefore, in order to further validate our findings re-
garding methylation and gene expression levels, we per-
formed flow cytometric analyses for GPR15 protein
expression in WBCs and PBMCs in our replication co-
hort. We found that CD3+ T cells were the main popu-
lation expressing GPR15. The proportion of these cells
was nearly 5-fold increased in smokers. To a less extent,
CD19+ B cells were responsible for the GPR15 expres-
sion in whole blood (Fig. 2).Without further characterization of cell subtypes, it
has long been known that smoking changes leukocyte
count in whole blood [25, 26]. Here, we demonstrate
that within leukocytes, only a particular immune subset
was associated with smoking, this subset being enriched
in the peripheral blood of smokers. To our knowledge,
to date, GPR15-expressing T cells seem to be the stron-
gest cellular determinant in whole blood in discriminat-
ing individually active smokers from non-smokers.
Based on the frequency of GPR15-bearing CD3+ T cells,
a specificity of 0.99 % was reached by flow cytometric
analysis of GRP15 expression.
The frequency of these cells was strongly correlated
with GPR15 gene expression at the WBC level, indicat-
ing that GPR15 gene expression detectable in blood is
mainly a result of the expression in CD3+GPR15+ T
cells. The lower correlation of GPR15 gene expression in
blood with the frequency of CD19+GPR15+ B cells may
be explained by the fact that only a small proportion of
cells in whole blood are B cells (1.5 %).
To find out the origin of methylation changes at
cg19859270 due to smoking habit, we investigated the
methylation at this CpG site in PBMCs as well as sorted
CD3+GPR15- and CD3+GPR15+ cells from smokers
and non-smokers. Here, for the first time, we show that
the hypomethylation at cg19859270 within the GPR15
gene is strongly associated with the GPR15 protein expres-
sion and is independent of smoking habit. Irrespective of
whether the isolated CD3+GPR15+ cells originated from
smokers or non-smokers, these cells carry about 50 %
methylation at cg19859270 compared to a greater than
90 % methylation in the CD3+GPR15- population in each
WBC sample of blood donor, leading to the assumption
of a monoallelic expression of GPR15. Besides this
GPR15-associated methylation pattern at cg19859270, the
hypomethylation in CD3+GPR15+ cells was slightly more
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mains speculative and warrants further investigations
which are in focus of future studies.
The apparent smoking-dependent observed difference
in cg19859270 methylation at the PBMC or WBC level
to an extent seen by ourselves and others of 2–4 %
[1–7] seems to be determined by the enrichment of spe-
cific cg19859270 hypomethylated cell population in
smokers. To statistically evaluate this observation, we an-
alyzed the impact of smoking habit on cg19859270
methylation at the PBMC level by using a multiple linear
regression model. In univariate analyses, smoking habit
and the proportion of CD3+GPR15+ T cells are both in-
dependently associated with PBMC methylation. Neither
gender, age, nor the proportion of CD3+ T cells had an
influence on PBMC methylation. However, when the
model with the PBMC methylation as the outcome and
smoking habit as predictor was adjusted, besides age and
gender, to the proportion of CD3+GPR15+ expressing
cells, the positive association between smoking and
cg19859270 methylation lost significance.
Conclusion
With these findings, we want to point out, firstly, the
eminent importance of cell subtype adjustment in
EWAS. As we show here, an adjustment only at the level
of known cell lineage markers [4, 5, 7] does not over-
come the cell composition bias in general. Thus, for
EWAS, it is strongly recommended to exclude a cell type
specificity for all significant findings.
Secondly, we want to point out, that the smoking-
induced hypomethylation at cg19859270 in WBC is not
caused by direct action of smoking-related soluble com-
pounds. In vitro experiments with cigarette smoking ex-
tract (CSE) did not increase the proportion of these
GPR15-bearing cells, indicating that CSE is not respon-
sible for the hypomethylation at CpG site cg19859270
located in the gene body of GPR15. To reiterate, these
result underline that there is no causative effect of
cigarette smoking on DNA methylation observed at the
WBC or PBMC level at least for the cg19859270 locus.
How tobacco smoke may increase the proportion of
GPR15-expressing T cells in the peripheral blood of
active smokers remain to be elucidated and requires
in vivo studies which were not performed in the present
investigation, representing a limitation of our study.
However, excluding a direct action of CSE on the pro-
portion of GPR15-expressing T cell in vitro, we favor the
hypothesis of a complex immunological cascade toward
tobacco-smoking-induced disturbance of tissue homeo-
stasis including the interaction of antigen-presenting
cells. One other limitation of our study is that we validated
only one, GPR15, of the genes whose expression was differ-
entially expressed in smokers compared to non-smokers.Thus, although we cannot generalize our findings to other
CpGs or other environmental exposures, it might serve as
an example for the misleading situation when differences at
the methylation level, even after replication at the gene
expression level, lead to false assumptions especially
when further validation at the protein and cellular level
is not performed.
We suggest that even though in many EWAS performed
in whole blood an adjustment for cellular composition has
been made, these corrected descriptive results should be
interpreted with caution when the cell subtype expressing
the differentially methylated gene is not identified.
Methods
Subjects
For the present study, data from two independent human
cohorts were used (Table 4). A workplace selected cohort
comprising 107 volunteers employing in industrial duck
production (Working Place Cohort) located in the federal
state Brandenburg (Germany). This study was designed to
assess the impact of workplace dust on human health.
Blood samples were collected in PAXgene Blood RNA
Tube (Qiagen, Hilden, Germany) at one working day be-
fore and after work. All participants gave written informed
consent. The study was approved by the ethics commission
of the medical association of Berlin (eth-013/07). The sec-
ond cohort, used as replication cohort, comprised 123 ran-
domly selected pseudonymous blood samples from healthy
volunteers. These samples consisted of 100 venous whole
blood samples as well as 23 buffy coats, obtained from the
Institute of Transfusion Medicine at the University of
Leipzig, Germany. All volunteers were HIV-tested negative
and gave written informed consent. The study was ap-
proved by Ethics Committees of the University of Leipzig
(079-15-09032015). In both cohorts, smoking behavior,
age, and gender were recorded via questionnaires.
Sample preparation
Total RNA was prepared from blood samples by PAX-
gene Blood RNA Kit (Qiagen, Hilden, Germany) and
from isolated PBMCs from buffy coat by using peqGold
RNA Pure (peqlab, Erlangen, Germany), according to
manufacturer’s instructions. The cDNA synthesis was
carried out with 1 μg of RNA by using ImProm-II™ Reverse
Transcription System (Promega, Mannheim, Germany).
Gene expression analysis
Working Place Cohort
In the Working Place Cohort, multiple genes (159 genes,
see Additional file 1) were analyzed by 96.96 Dynamic
Array (Fluidigm, San Francisco, CA, USA). Intron-
spanning primers were designed, and UPL probes were
selected by the Universal Probe Library Assay Design
Center (http://qpcr.probefinder.com/organism.jsp). A
Table 4 Description of human specimens
Male Female Cell population Expression
Working Place Cohort WBCb Gene
Gender 52 41
Agea 44 (24–72) 43.5 (21–70)
Tobacco smoking
Non-smoker 20 11
Formerly smoker 9 11
Smoker
<10 cigarettes/day 4 5
>10 cigarettes/day 19 14
Replication cohort WBCb Gene, protein
WBC
Gender 53 47




Buffy coat PBMCc gDNA-methylation, protein
Gender 14 9






cPeripheral blood mononuclear cells
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all primers (final concentration, 50 nM), 5 μl of
cDNA, and 2X PreAmp Master Mix (Applied Biosys-
tems/Life Technologies GmbH, Darmstadt, Germany).
The cycling program consisted of 95 °C for 10 min,
followed by 14 cycles of 95 °C for 15 s, and 60 °C for
4 min on a LightCycler 480 (Roche Applied Science,
Mannheim, Germany). The qPCRs of 1:5 diluted with
TE buffer preamplified templates were performed fol-
lowing manufacturer's instruction for UPL (Roche,
Mannheim, Germany) assays. Briefly, for each individ-
ual assay, a 10X Assay Mix that contained 2 μM of
each forward and reverse primers, 1 μM UPL probe
and 0.025 % Tween-20 were prepared, and 5 μl of the
mix was loaded into the assay inlets of the array. Into
the sample inlets, 5 μl of the following solution was
dispensed: 2.5 μl of PreAmp sample in 1.1X of
FastStart Universal Probe Master Mix (Roche, Mann-
heim, Germany). The cycling program consisted of
2 min at 50 °C, 10 min at 95 °C, followed by 35 cycles
of 95 °C for 15 s, 1 min at 60 °C, and 70 °C for 5 s. All
reactions were performed in triplicates. Gene expres-
sion values were determined by using the 2−ΔΔCTmethod [27] and GAPD and GUSB as reference genes
and normalized to the lowest measured value.
Replication Cohort
Specific single gene expressions were performed for
GPR15 (primer-for 5′-tggctgcccttcaatacttt, -rev 5′-tag
tgttcttgccgcaacc, UPL 72) and reference genes GAPD
and GUSB (primer-for 5′-gctctctgctcctcctgttc, -rev 5′-
acgaccaaatccgttgactc, UPL 60; -for 5′-cgccctgcctatctg-
tattc, -rev 5′-tccccacagggagtgtgtag, UPL 57) with identical
PCR-mix as described above in 384-well format on a
LightCycler 480 cycler (Roche, Mannheim, Germany).
Analysis of protein expression at cellular level
The translation of differentially expressed gene GPR15
in smoker vs. non-smoker was analyzed at cellular level
via flow cytometry. In the Replication Cohort, 100 μl of
whole blood was incubated with mouse-anti-human-
GPR15 antibody (1:500; R&D Systems, Wiesbaden-
Nordenstadt, Germany) supplemented with 5 % goat
serum for 1 h. After washing in PBS/1% fetal calf serum
(FCS), the GPR15 was stained with R-phycoerythrin-
labeled goat-anti-mouse IgG2b (1:500, 1 h; Biozol, Eching,
Bauer et al. Clinical Epigenetics  (2015) 7:81 Page 10 of 11Germany) following an additional wash step. Thereafter,
cells were incubated with 5 % mouse serum for 30 min fol-
lowing double-staining step for leucocyte differentiation
marker (1 h; anti-CD3-FITC (Beckman Coulter, Krefeld,
Germany)), -CD4-BV510, -CD8-PerCP, and -CD19-APC-
H7 (BD Biosciences, Heidelberg, Germany). At the end,
erythrocytes were lysed in FACS Lysing solution (BD Bio-
science, Heidelberg, Germany) according to manufacturer’s
instruction immediately before measurement.
Isolated PBMCs from buffy coats were stained for
GPR15 and thereafter for the other surface receptors
according to the above mentioned method but without
erythrocyte lysing step. All measurements were per-
formed on a FACS Canto II and analyzed with the BD
FACSDIVA software (version 8.0.1, BD Biosciences,
Heidelberg, Germany).
Analysis of methylation differences in flow-sorted cells
For GPR15-specific cell sorting, PBMCs were isolated
from buffy coats and stained as mentioned above.
CD3+GPR15+ cell populations were sorted with pur-
ity greater than 99 %. Flow cytometric cell sorting
was performed at the laboratory of cytometry of the
Core Facility at the University of Leipzig.
Pyrosequencing
Genomic DNA was extracted from PBMC by using the
Blood DNA extraction kit according to the manufac-
turer’s protocol (Qiagen, Hilden, Germany). DNA bisul-
fite treatment was performed using the Epitect kit
(Qiagen) according to manufacturer’s instruction. Sam-
ples were immediately stored at −20 °C and thereafter
simultaneously analyzed by pyrosequencing. Methylation
assays were designed using the PyroMark Assay Design
Software 2.0 (www.qiagen.com). Primer sequences for
pyrosequencing are indicated in Additional file 4.
Methylation levels for the CpG site were assessed using
Pyromark Q24 pyrosequencer (Qiagen).
Validation of smoking behavior—Cotinine ELISA
Smoking behavior in the Replication Cohort was validated
by cotinine measurements. The cotinine concentration in
plasma of blood or blood buffy coat samples was measured
using the Cotinine direct ELISA Kit according to manufac-
turer’s instruction (DRG Instruments GmbH, Marburg,
Germany). Cotinine level exceeding the sensitivity level of
the assay (1 ng/ml) was considered as smoker.
Preparation of aqueous cigarette smoke extract (CSE)
CSE was prepared according to the protocol described
by Adenuga and co-workers [28]. Briefly, research-grade
reference cigarettes (3R4F) from the University of
Kentucky (Tobacco Health Research, Lexington, KY, USA)
were used to prepare cigarette smoke extract (CSE) byslowly bubbling smoke from one cigarette into 10 ml of
RPMI 1640 without supplements at a rate of 1 cigarette/
min. Afterwards, CSE was sterile-filtered through a 0.22-
μm filter (Sartorius, Göttingen, Germany).In vitro exposure of PBMCs
Peripheral blood mononuclear cells (PBMCs) from blood
or from blood buffy coat were obtained by density-gradient
centrifugation using Ficoll-Paque (GE Healthcare, Berlin,
Germany). After separation cells were immediately cultured
or cryopreserved and stored in liquid nitrogen. PBMCs
(5 × 105 cells/well) were held in vitro culture in 96-well
round-bottom plates with RPMI 1640 medium supple-
mented with 10 % FCS, glutamine, and 25 mM HEPES
(Life Technologies, Darmstadt, Germany) without antibi-
otics. CSE was added in concentrations 1:1000, 1:100, and
1:10. After 5 days, cells were harvested and analyzed by
flow cytometry as mentioned before.Statistical analysis
Statistical significance of parametric distributed values was
calculated with unpaired Student’s t test. Otherwise, the
nonparametric Mann-Whitney U test was applied for com-
parison of dependent and independent variables, respect-
ively (Statistica for Windows version 10, StatSoft Inc.,
Europe). Boxes in figures indicate the 25 and 75 % percen-
tiles, whiskers the non-outlier range and dots the outlier.
All p values <0.05 were considered to be significant. In ana-
lyzing gene expression data (159 genes) from high-
throughput approach, the Bonferroni correction for mul-
tiple testing (p < 0.00031) was considered to be significant
(Additional file 1). The sensitivity and specificity as statis-
tical measures of performance of GPR15-dependent dis-
crimination between smokers and non-smokers were
calculated.
To test the relationship between smoking and DNA
methylation, we used a multiple linear regression model
with methylation at PBMC level as outcome (Methyl-
PBMC) and smoking habit as predictor. The model was
further adjusted to age, gender, and the proportion of
CD3+ T cells or CD3+GPR15+ T cells. These possible
confounders for Methyl-PBMC were tested also in uni-
variate analyses.Additional files
Additional file 1: A table listing “Comparison of gene expression
(n=159) in smokers (s) versus non-smokers (ns) of the Work Place
Cohort. Differences in gene expression were estimated by t-test.
Significant values after Bonferroni correction for multiple testing
(p<0.00031) are held in bold”.
Additional file 2: A figure showing “GPR15 gene expression versus
circadian rhythm. For the Working Place Cohort, peripheral blood was
collected before (morning) and after (afternoon) work”.
Bauer et al. Clinical Epigenetics  (2015) 7:81 Page 11 of 11Additional file 3: A figure showing “Representative dot plots for
the gating strategy for isotype control and GPR15 staining. Gated
lymphocytes were further characterized for the expression of CD3 and CD19.
Additional file 4: A table listing “Primer sequences used for
pyrosequencing”.
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